Bernard Cambou, PhD, MBA
Dr. Cambou is an industry leader in the biotech-pharma drug development spectrum where he has held several C-suite positions at leading biotech companies including Principia Pharmaceuticals, Cellatope, Cytomics and Targazyme. He has also been a Venture Capital Partner with Birchmere Ventures, a life sciences investment firm.
Dr. Cambou received his PhD in biochemistry from the Université de Technologie de Compiègne and MBA from Essec, Paris.
On December 26, 2020 /
A late-stage clinical biotech company developing therapies for ultra-rare pediatric orphan diseases